These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 16979156)

  • 1. Selection of new chemical entities with decreased potential for adverse drug reactions.
    Park KB; Dalton-Brown E; Hirst C; Williams DP
    Eur J Pharmacol; 2006 Nov; 549(1-3):1-8. PubMed ID: 16979156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicophores: investigations in drug safety.
    Williams DP
    Toxicology; 2006 Sep; 226(1):1-11. PubMed ID: 16860917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are chemically reactive metabolites responsible for adverse reactions to drugs?
    Williams DP; Kitteringham NR; Naisbitt DJ; Pirmohamed M; Smith DA; Park BK
    Curr Drug Metab; 2002 Aug; 3(4):351-66. PubMed ID: 12093355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
    Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
    Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
    Hess DA; Rieder MJ
    Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of reactive metabolites in drug-induced hepatotoxicity.
    Srivastava A; Maggs JL; Antoine DJ; Williams DP; Smith DA; Park BK
    Handb Exp Pharmacol; 2010; (196):165-94. PubMed ID: 20020263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug bioactivation, covalent binding to target proteins and toxicity relevance.
    Zhou S; Chan E; Duan W; Huang M; Chen YZ
    Drug Metab Rev; 2005; 37(1):41-213. PubMed ID: 15747500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science.
    Antoine DJ; Williams DP; Park BK
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1415-27. PubMed ID: 18950283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug damage to the liver: role of reactive metabolites and pharmacokinetics].
    Lauterburg BH
    Schweiz Med Wochenschr; 1985 Sep; 115(38):1306-12. PubMed ID: 3933110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation in drug-induced liver injury.
    Leung L; Kalgutkar AS; Obach RS
    Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting reactive drug metabolites for reducing the potential for drug toxicity.
    Grillo MP
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1281-302. PubMed ID: 26005795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: correlation to in vitro drug metabolism.
    Madsen KG; Olsen J; Skonberg C; Hansen SH; Jurva U
    Chem Res Toxicol; 2007 May; 20(5):821-31. PubMed ID: 17447796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs].
    Pessayre D; Benhamou JP
    C R Seances Soc Biol Fil; 1979; 173(2):458-68. PubMed ID: 159767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive metabolites as a cause of hepatotoxicity.
    Prescott LF
    Int J Clin Pharmacol Res; 1983; 3(6):437-41. PubMed ID: 6381340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the liabilities arising from structural alerts: a safe philosophy for medicinal chemists.
    Edwards PJ; Sturino C
    Curr Med Chem; 2011; 18(20):3116-35. PubMed ID: 21651480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity.
    Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP
    Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of metabolic activation in drug-induced hepatotoxicity.
    Park BK; Kitteringham NR; Maggs JL; Pirmohamed M; Williams DP
    Annu Rev Pharmacol Toxicol; 2005; 45():177-202. PubMed ID: 15822174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation and bound residues.
    Burgat-Sacaze V; Rico A; Delatour P
    Food Addit Contam; 1984; 1(2):121-9. PubMed ID: 6536524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of CYP102A1M11H as a tool for the generation of protein adducts of reactive drug metabolites.
    Boerma JS; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2011 Aug; 24(8):1263-74. PubMed ID: 21639118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions.
    Petersen KU
    Arzneimittelforschung; 2002; 52(6):423-9. PubMed ID: 12109041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.